Barclays initiated coverage of Zymeworks Inc (NYSE: ZYME) with an Overweight rating and price target of $20.
May 23, 2017 at 11:15PM
from Ezra Schwarzbaum
Featured Post
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment